Circulating microRNAs as novel biomarkers for diabetes mellitus

Cited by (565)

Items 201–300 of 565

1. Epigenetics and Cardiovascular Disease in Diabetes
   Jennifer Pasquier, Jessica Hoarau-Véchot, Khalid Adnan Fakhro, Arash Rafii, Charbel Abi Khalil · 2015 · Current Diabetes Reports
2. MicroRNAs in CD4+ T cell subsets are markers of disease risk and T cell dysfunction in individuals at risk for type 1 diabetes
   Yuxia Zhang, Zhi-Ping Feng, Gaetano Naselli, Fiona Bell, James M. Wettenhall, Priscilla Auyeung, Justine A. Ellis, Anne‐Louise Ponsonby, Terence Paul Speed, Mark M. W. Chong et al. · 2016 · Journal of Autoimmunity
3. The role of miRNAs in polycystic ovary syndrome with insulin resistance
   Yingliu Luo, Chenchen Cui, Xiao Han, Qian Wang, Cuilian Zhang · 2021 · Journal of Assisted Reproduction and Genetics
4. Potential role of microRNAs in the regulation of adipocytes liposecretion and adipose tissue physiology
   Giulia Maurizi, Lucia Babini, Lucio Della Guardia · 2018 · Journal of Cellular Physiology
5. Improved physiology and metabolic flux after Roux-en-Y gastric bypass is associated with temporal changes in the circulating microRNAome: a longitudinal study in humans
   Abdullah Alkandari, Hutan Ashrafian, Thozhukat Sathyapalan, Peter C. Sedman, Ara Wardkes Darzi, Elaine C. Holmes, Thanos Athanasiou, Stephen Lawrence Atkin, Nigel J. Gooderham · 2018 · BMC Obesity
6. Serum miRNA-371b-5p and miRNA-5100 act as biomarkers for systemic lupus erythematosus
   Li Zeng, Jiali Wu, Limin Liu, Juqing Jiang, Haijing Wu, Ming Zhao, Qianjin Lu · 2018 · Clinical Immunology
7. The role of microRNAs in the healing of diabetic ulcers
   Golnaz Goodarzi, Mahmood Maniati, Durdi Qujeq · 2019 · International Wound Journal
8. Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
   Ana Pérez-García, Marta Torrecilla-Parra, Mario Fernández-de Frutos, Yolanda Martín-Martín, Virginia Pardo, Cristina M. Ramírez · 2022 · Biomolecules
9. Proximity sensitive detection of microRNAs using electrochemical impedance spectroscopy biosensors
   Appan Roychoudhury, James W. Dear, Till T. Bachmann · 2022 · Biosensors and Bioelectronics
10. Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes
    Garavelli, Silvia, Bruzzaniti, Sara, Tagliabue, Elena, Di Silvestre, Dario, Prattichizzo, Francesco, Mozzillo, Enza, Fattorusso, Valentina, La Sala, Lucia, Ceriello, Antonio, Puca, Annibale A. et al. · 2020 · Diabetologia
11. Quercetin‑conjugated superparamagnetic iron oxide nanoparticles modulate glucose metabolism-related genes and miR-29 family in the hippocampus of diabetic rats
    Solmaz Dini, Mansoureh Zakeri, Shiva Ebrahimpour, Fariba Dehghanian, Abolghasem Esmaeili · 2021 · Scientific Reports
12. The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus
    Simranjeet Kaur, Aashiq Hussain Mirza, Caroline Brorsson, Tina Fløyel, Joachim Størling, Henrik Bindesbøl Mortensen, Flemming Pociot · 2015 · Molecular and Cellular Endocrinology
13. Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins
    Wei‐Ming Chen, Wayne Huey‐Herng Sheu, Pei‐Chi Tseng, Tzong‐Shyuan Lee, Wen‐Jane Lee, Pey‐Jium Chang, An‐Na Chiang · 2016 · PLoS ONE
14. Circulating levels of miR-7, miR-152 and miR-192 respond to vitamin D supplementation in adults with prediabetes and correlate with improvements in glycemic control.
    Y. O. Nunez Lopez, A. Pittas, R. Pratley, A. Seyhan · 2017 · Journal of Nutritional Biochemistry
15. Cross‐linking gold nanoparticles aggregation method based on localised surface plasmon resonance for quantitative detection of miR‐155
    Aghil Esmaeili‐bandboni, Seyed Mohammad Amini, Reza Faridi Majidi, Jamshid Bagheri, Javad Mohammadnejad, Esmaeil Sadroddiny · 2017 · IET Nanobiotechnology
16. miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
    Giuliana Ventriglia, Francesca Mancarella, Guido Sebastiani, Dana Paulina Cook, Roberto Mallone, Chantal Mathieu, Conny A. Gysemans, Francesco Dotta · 2019 · Diabetologia
17. Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy
    Marcelle SanJuan Ganem Prado, Mirthz Lemos de Jesus, Thaline Cunha de Goes, Lucilla Silva Oliveira Mendonça, Carla Martins Kaneto · 2020 · BMC Research Notes
18. Recent Highlights of Research on miRNAs as Early Potential Biomarkers for Cardiovascular Complications of Type 2 Diabetes Mellitus
    Agnieszka Bielska, Magdalena Niemira, Adam Jacek Kretowski · 2021 · International Journal of Molecular Sciences
19. Urinary miR-196a predicts disease progression in patients with chronic kidney disease
    Changming Zhang, Shaoshan Liang, Shuiqin Cheng, Wei Li, Xia Wang, Chunxia Zheng, Caihong Zeng, Shaolin Shi, Lu Xie, Ke Zen et al. · 2018 · Journal of Translational Medicine
20. Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
    Miruna Nemecz, Diana Simona Stefan, Ioana Karla Comariţa, Alina Liliana Constantin, Gabriela Tanko, Cristian Guja, Adriana Georgescu · 2023 · Cardiovascular Diabetology
21. Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA‐2, IA‐2β, and GAD65
    Liron Abuhatzira, Huanyu Xu, Georges Tahhan, Afroditi Boulougoura, Alejandro A. Schäffer, Abner Louis Notkins · 2015 · The FASEB Journal
22. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections
    Matteo Sérino · 2018 · Journal of Molecular Biology
23. Effects of Aerobic and Resistance Training on Circulating Micro-RNA Expression Profile in Subjects With Type 2 Diabetes
    Debora Olioso, Marco Dauriz, Elisabetta Bacchi, Carlo Negri, Lorenza Santi, Enzo Bonora, Paolo Moghetti · 2018 · The Journal of Clinical Endocrinology & Metabolism
24. Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic Options
    Erika Cione, Roberto Cannataro, Luca Gallelli, Giovambattista De Sarro, Maria Cristina Caroleo · 2021 · Pharmaceuticals
25. Extracellular vesicles and their non‐coding RNA cargos: Emerging players in cardiovascular disease
    Aida Collado, Lu Gan, John Tengbom, Eftychia Kontidou, John Pernow, Zhichao Zhou · 2022 · The Journal of Physiology
26. Noninvasive On-Skin Biosensors for Monitoring Diabetes Mellitus
    Ali Sedighi, Tianyu Kou, Hui Huang, Yi Li · 2025 · Nano-Micro Letters
27. Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis
    Sara Nunes, Ícaro Bonyek-Silva, Mariana Rosa Ampuero, Almério Libório Lopes de Noronha, Lígia Correia Lima de Souza, Thaizza Cavalcante Correia, Ricardo Khouri, Viviane Sampaio Boaventura, Aldina Maria Prado Barral, Pablo Ivan Pereira Ramos et al. · 2018 · Frontiers in Immunology
28. Circulating miR-103 family as potential biomarkers for type 2 diabetes through targeting CAV-1 and SFRP4
    Mao Luo, Chunrong Xu, Yulin Luo, Gang Wang, Jianbo Wu, Qin Wan · 2019 · Acta Diabetologica
29. Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
    Pernille Bækgaard Udesen, Dorte Glintborg, Anja E. Sørensen, Rikke Pilsgaard Svendsen, Nanna Lond Skov Frisk, Marie Louise Wissing, Marianne Andersen, Anne Lis Mikkelsen Englund, Louise T. Dalgaard · 2020 · Endocrine Connections
30. Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets?
    Maria Consiglia Trotta, Carlo Gesualdo, Chiara Bianca Maria Platania, Domenico De Robertis, Mauro Giordano, Francesca Simonelli, Michele D’Amico, Filippo Drago, Claudio Bucolo, Settimio Rossi · 2021 · Biochemical Pharmacology
31. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond
    Rounak Nassirpour, Dominic Raj, Raymond R. Townsend, Christos Argyropoulos · 2016 · Food and Chemical Toxicology
32. Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk
    Sarah A. Aroner, Ming Yang, Junlong Li, Jeremy D. Furtado, Frank M. Sacks, Anne Marie Tjønneland, Kim Overvad, Tianxi Cai, Majken K. Jensen · 2017 · American Journal of Epidemiology
33. Retracted: Downregulation of long noncoding RNA H19 rescues hippocampal neurons from apoptosis and oxidative stress by inhibiting IGF2 methylation in mice with streptozotocin‐induced diabetes mellitus
    Jinlu Yu, Chao Li, Lihe Che, Yuhao Zhao, Yunbao Guo · 2018 · Journal of Cellular Physiology · Retracted
34. Gestational diabetes and maternal obesity are associated with sex-specific changes in miRNA and target gene expression in the fetus
    Apoorva S. Joshi, Rikka Azuma, Rita C. Akumuo, Laura M. Goetzl, Sara Elizabeth Pinney · 2019 · International Journal of Obesity
35. Circulating miRNAs as Potential Biomarkers for Celiac Disease Development
    Ineke L. Tan, Rodrigo Coutinho de Almeida, Rutger Modderman, Anna Stachurska, Jackie A. M. Dekens, Donatella Barisani, Caroline R. Meijer-Boekel, María Roca, Eva Martínez‐Ojinaga, Raanan Shamir et al. · 2021 · Frontiers in Immunology
36. Islet microRNAs in health and type-2 diabetes
    Anna Wendt, Jonathan L.S. Esguerra, Lena Eliasson · 2018 · Current Opinion in Pharmacology
37. Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling
    Jasper Anckaert, Francisco Avila Cobos, Anneleen Decock, Philippe Decruyenaere, Jill Deleu, Katleen De Preter, Olivier De Wever, Jilke De Wilde, Bert Dhondt, Thibaut D’huyvetter et al. · 2025 · Nature Communications
38. Comprehensive analysis of blood cells and plasma identifies tissue-specific miRNAs as potential novel circulating biomarkers in cattle
    Jason Ioannidis, Francesc Xavier Donadeu · 2018 · BMC Genomics
39. MicroRNA single‐nucleotide polymorphisms and diabetes mellitus: A comprehensive review
    Yanfen Zhang, Ruocen Bai, Chong Liu, Chunyan Ma, Xin Chen, Jun Yang, Dandan Sun · 2018 · Clinical Genetics
40. MiR-1908/EXO1 and MiR-203a/FOS, regulated by scd1, are associated with fracture risk and bone health in postmenopausal diabetic women
    Yisheng Chen, Xueran Kang, Zi-hui Zhou, Yang Jiang, Qi Xin, Chenting Ying, Yunpeng Zhang, Jie Tao · 2020 · Aging
41. Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins
    Marcus Bauer, Christoforos Vaxevanis, Nadine Heimer, Haifa Kathrin Al‐Ali, Nadja Jaekel, Michael Philipp Bachmann, Claudia Wickenhauser, Barbara Seliger · 2020 · International Journal of Molecular Sciences
42. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients
    Ting-Yu Chang, Wei-Chi Tsai, Tse-Shun Huang, Shu–Han Su, Chih-Young Chang, Hsiu-Yen Ma, Chun‐Hsien Wu, Chih‐Yung Yang, Chi-Hung Lin, Po-Hsun Huang et al. · 2017 · PLoS ONE
43. The axis of long non-coding RNA MALAT1/miR-1-3p/CXCR4 is dysregulated in patients with diabetic neuropathy
    Donya Ashjari, Negin Karamali, Misagh Rajabinejad, Seyedeh Sara Hassani, Leila Afshar Hezarkhani, Daryoush Afshari, Ali Gorgin Karaji, Farhad Salari, Alireza Rezaiemanesh · 2022 · Heliyon
44. MicroRNAs: a crossroad that connects obesity to immunity and aging
    Ahmed Rakib, Sonia Kiran, Mousumi Mandal, Udai Pratap Singh · 2022 · Immunity & Ageing
45. Upregulation of microRNA Processing Enzymes Drosha and Dicer in Gestational Diabetes Mellitus
    Giti Rahimi, Naser Jafari, Mehnoush Khodabakhsh, Zohreh Shirzad, Hadi Peeridogaheh · 2014 · Gynecological Endocrinology
46. Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 Diabetes
    Nasim Samandari, Aashiq Hussain Mirza, Simranjeet Kaur, Philip Hougaard, Lotte B. Nielsen, Siri Fredheim, Henrik Bindesbøl Mortensen, Flemming Pociot · 2018 · Non-Coding RNA
47. The structural shift of a DNA template between a hairpin and a dimer tunes the emission color of DNA-templated AgNCs
    Pratik Shah, Sukwon Choi, Riddhi Nagda, Reka Geczy, Seok Keun Cho, Yong Joo Bhang, Tae‐Hwan Kim, Tae Yang Song, Phil Hyu Lee, Ju-Hee Kang et al. · 2018 · Nanoscale
48. Circulatory miR-98-5p levels are deregulated during diabetes and it inhibits proliferation and promotes apoptosis by targeting PPP1R15B in keratinocytes
    Rukshar Khan, Vinitha Kadamkode, Devesh Kesharwani, Sudarshana Purkayastha, Gautam Banerjee, Malabika Datta · 2019 · RNA Biology
49. Inter‐Individual Variability in Insulin Response after Grape Pomace Supplementation in Subjects at High Cardiometabolic Risk: Role of Microbiota and miRNA
    Sara Ramos‐Romero, Asier Léniz, Daniel Martínez‐Maqueda, Susana Amézqueta, Alfredo Fernández‐Quintela, Mercè Hereu, Josep Luís Torres, María P. Portillo, Jara Pérez‐Jiménez · 2020 · Molecular Nutrition & Food Research
50. Effect of chronic consumption of pistachios (Pistacia vera L.) on glucose metabolism in pre-diabetics and type 2 diabetics: A systematic review
    Priscila Vaz de Melo Ribeiro, Alessandra da Silva, Alinne Paula de Almeida, Helen Hermana Miranda Hermsdorff, Rita de Cássia Gonçalves Alfenas · 2017 · Critical Reviews in Food Science and Nutrition
51. Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers
    Diego F. García‐Díaz, Carolina Pizarro, Patricia Camacho-Guillén, Ethel Codner D, Néstor Soto I, Francisco Pérez‐Bravo · 2018 · Archives of Endocrinology and Metabolism
52. Two-tailed RT-qPCR panel for quality control of circulating microRNA studies
    Peter Androvic, Nataliya Romanyuk, Lucia Machová Urdzíková, Eva Rohlová, Mikael Kubista, Lukáš Valihrach · 2019 · Scientific Reports
53. Does microRNA Perturbation Control the Mechanisms Linking Obesity and Diabetes? Implications for Cardiovascular Risk
    Lucia La Sala, Maurizio Crestani, S. Garavelli, Paola de Candia, Antonio Ettore Pontiroli · 2020 · International Journal of Molecular Sciences
54. Smartphone-Based Device for Colorimetric Detection of MicroRNA Biomarkers Using Nanoparticle-Based Assay
    Tushar Krishnan, Hsin‐Neng Wang, Tuan Vo‐Dinh · 2021 · Sensors
55. Assessment of DNA damage and mRNA/miRNA transcriptional expression profiles in hyperglycemic versus non-hyperglycemic patients with type 2 diabetes mellitus
    Danilo J. Xavier, Paula Takahashi, Adriane Feijó Evangelista, Maria Cristina Foss‐Freitas, Milton César Foss, Eduardo Antônio Donadi, Geraldo Aleixo Silva Passos, Elza Tiemi Sakamoto‐Hojo · 2015 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
56. Bioengineering Microgels and Hydrogel Microparticles for Sensing Biomolecular Targets
    Edmondo Battista, Filippo Causa, Paolo A. Netti · 2017 · Gels
57. Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes
    Zahra Azhir, Fariba Dehghanian, Zohreh Hojati · 2018 · Molecular Biology Reports
58. Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus and Diabetes-Associated Complications
    Ebrahim M Yimer, Kaleab Alemayehu Zewdie, Hailemichael Zeru Hishe · 2018 · Journal of Diabetes Research
59. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points
    Lucía Pinilla, Ivan David Benitez, Jessica González, Gerard Torres, Ferrán Barbé, David de Gonzalo‐Calvo · 2021 · RNA Biology
60. MicroRNA-23b-3p Deletion Induces an IgA Nephropathy-like Disease Associated with Dysregulated Mucosal IgA Synthesis
    Hongzhi Li, Zhichao Chen, Weitian Chen, Jingyi Li, Yunshuang Liu, Hongchuang Ma, Mingming Shi, Xuelian Sun, Xiusong Yao, Zhijun Li et al. · 2021 · Journal of the American Society of Nephrology
61. MicroRNAs regulating SOX2 in cancer progression and therapy response
    Sepideh Mirzaei, Hamidreza Saebfar, Mohammad Hossein Gholami, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Maliheh Entezari, Kiavash Hushmandi, Saeed Samarghandian, Amir Reza Aref et al. · 2021 · Expert Reviews in Molecular Medicine
62. miRNAs and lncRNAs: Potential Non-Invasive Biomarkers for Endometriosis
    Ioana Maria Maier, Adrian Cornel Maier · 2021 · Biomedicines
63. Circular RNAs in hypertension: challenges and clinical promise
    Mohamed Zaiou · 2019 · Hypertension Research
64. Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria
    Francesca Remelli, Elisa Maietti, Pasquale Abete, Giuseppe Bellelli, Mario Bo, Antonio Cherubini, Francesco Corica, Mauro Di Bari, Marcello Giuseppe Maggio, Maria Rosaria Rizzo et al. · 2021 · Aging Clinical and Experimental Research
65. Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?
    Weronika Kraczkowska, Lucyna Stachowiak, Andrzej Pławski, Paweł Piotr Jagodziński · 2022 · Journal of Applied Genetics
66. Human umbilical cord mesenchymal stromal cell small extracellular vesicle transfer of microRNA-223-3p to lung epithelial cells attenuates inflammation in acute lung injury in mice
    Jie Chen, Shiyang Ma, Baihua Luo, Haojie Hao, Yanqin Li, Hang Yang, Fei Zhu, Peipei Zhang, Ruichao Niu, Pinhua Pan · 2023 · Journal of Nanobiotechnology
67. MicroRNAs and adipocytokines: Promising biomarkers for pharmacological targets in diabetes mellitus and its complications
    Mohammad Reza Ashoori, Mohammad Rahmati‐Yamchi, Alireza Ostadrahimi, Sedigheh Fekri Aval, Nosratollah Zarghami · 2017 · Biomedicine & Pharmacotherapy
68. Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
    Jisu Oh, Amy Elizabeth Riek, Kevin Thomas Bauerle, Adriana Dusso, Kyle P. McNerney, Ruteja A. Barve, Isra Darwech, Jennifer Sprague, Clare Moynihan, Rong Mei Zhang et al. · 2023 · Nature Communications
69. Screening for microRNA-based diagnostic markers in hepatic alveolar echinococcosis
    Bin Ren, Haijiu Wang, Li Ren, Yangdan Cairang, Ying Zhou, Haining Fan, Yi Lv · 2019 · Medicine
70. High-efficient Pt@COF nanospheres-based electrochemical-chemical-chemical redox cycling for ultrasensitive microRNAs biosensing
    Xiaolun Peng, Junlun Zhu, Zhen Wu, Wei Wen, Xun Zhang, Miaomiao Chen, Shengfu Wang · 2023 · Sensors and Actuators B Chemical
71. Metabolic memory: mechanisms and implications for diabetic vasculopathies
    Erli Zhang, Yongjian Wu · 2014 · Science China Life Sciences
72. Melatonin Modulates the Immune System Response and Inflammation in Diabetic Rats Experimentally-Induced by Alloxan
    Seçkin Özkanlar, Adem Kara, Emin Şengül, N. Şi̇mşek, Ali Karadeniz, N. Kurt · 2015 · Hormone and Metabolic Research
73. Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db- mouse kidney
    Guankui Du, Man Xiao, Xuezi Zhang, Maoyu Wen, Chi Pang, Shangfei Jiang, Shenggang Sang, Yiqiang Xie · 2017 · Biological Research
74. MicroRNA-204-3p Attenuates High Glucose-Induced MPC5 Podocytes Apoptosis by Targeting Braykinin B2 Receptor
    Xu Han, Qiaobei Li, Chunyan Wang, Yinyan Li · 2018 · Experimental and Clinical Endocrinology & Diabetes
75. Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
    Ari Meerson, Azwar Najjar, Elias Saad, Wisam Sbeit, Masad Barhoum, Nimer Assy · 2019 · Non-Coding RNA
76. Review: Bio-compartmentalization of microRNAs in exosomes during gestational diabetes mellitus
    Juvita Delancy Iljas, Dominic Guanzon, Omar Wahid Mohamed Elfeky, Gregory Edward Rice, Carlos Salomón · 2016 · Placenta
77. The Association of Plasma Levels of Mir-34A and Mir-149 with Obesity and Insulin Resistance in Obese Children and Adolescents
    Fatemeh Ahmadpour · 2018 · Acta Endocrinologica (Bucharest)
78. Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis
    Anvarsadat Kianmehr, Durdi Qujeq, Abouzar Bagheri, Abdolkarim Mahrooz · 2021 · Critical Reviews in Clinical Laboratory Sciences
79. microRNAs as cancer biomarkers
    Kjersti Flatmark, Eirik Høye, Bastian Fromm · 2016 · Scandinavian Journal of Clinical and Laboratory Investigation
80. Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial
    Lide Arenaza, María Medrano, María Amasene, Beatriz Rodríguez‐Vigil, Ignacio Díez López, Manuel Graña, Ignacio Tobalina, Edurne Maíz, E. Arteche, Eider Larrarte et al. · 2017 · Trials
81. Retracted:Micro RNA ‐219 decreases hippocampal long‐term potentiation inhibition and hippocampal neuronal cell apoptosis in type 2 diabetes mellitus mice by suppressing the NMDAR signaling pathway
    Ling Zhang, Zheng‐Wen Chen, Shufen Yang, Muyasi Shaer, Ying Wang, Jun‐Jie Dong, Beili Jiapaer · 2018 · CNS Neuroscience & Therapeutics · Retracted
82. The Cognitive decline in Older Patients with End stage renal disease (COPE) study – rationale and design
    Noeleen C. Berkhout-Byrne, Marije H. Kallenberg, André Gaasbeek, Ton J. Rabelink, Sebastiaan Hammer, Mark A. van Buchem, Matthias J.P. van Osch, Lucia J.M. Kroft, Henk Boom, Simon P. Mooijaart et al. · 2017 · Current Medical Research and Opinion
83. Roles and regulatory mechanisms of miR‑30b in cancer, cardiovascular disease, and metabolic disorders (Review)
    Qing Hua Zhang, Shousheng Liu, Jie Zhang, Xuefeng Ma, Mengzhen Dong, Baokai Sun, Yongning Xin · 2020 · Experimental and Therapeutic Medicine
84. Inhibition of miR‐155 Attenuates Detrimental Vascular Effects of Tobacco Cigarette Smoking
    Giacomo Frati, Maurizio Forte, Flavio Di Nonno, Antonella Bordin, Isotta Chimenti, Vittorio Picchio, Elena Cavarretta, Rosita Stanzione, Franca Bianchi, Roberto Carnevale et al. · 2020 · Journal of the American Heart Association
85. Serum miRNA Profile in Diabetic Patients With Ischemic Heart Disease as a Promising Non-Invasive Biomarker
    Agnieszka Bielska, Witold Bauer, Anna Szałkowska, Iwona Sidorkiewicz, Anna Skwarska, Justyna Raczkowska, Damian Ostrowski, Kamil Gugała, Slawomir Dobrzycki, Magdalena Niemira et al. · 2022 · Frontiers in Endocrinology
86. Impacts of MicroRNA-483 on Human Diseases
    Katy Matson, Aaron Macleod, Nirali Mehta, Ellie Sempek, Xiaoqing Tang · 2023 · Non-Coding RNA
87. MicroRNA-22-3p as a novel regulator and therapeutic target for autoimmune diseases
    Bin Wang, Qiuming Yao, Donghua Xu, Jin‐an Zhang · 2017 · International Reviews of Immunology
88. Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes
    Joyita Banerjee, Swagata Roy, Yogita Dhas, Neetu Mishra · 2019 · Clinical and Experimental Medicine
89. Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome
    Margaritis Avgeris, Ioanna Kokkinopoulou, Eirini Maratou, Panagiota Mitrou, Eleni I. Boutati, Andreas Scorilas, Emmanuel G. Fragoulis, Maria Christodoulou · 2020 · Diabetes Research and Clinical Practice
90. miR-132-3p is a positive regulator of alpha-cell mass and is downregulated in obese hyperglycemic mice
    Rodolphe Dusaulcy, Sandra Handgraaf, Florian Visentin, Christian Vesin, Jacques Philippé, Yvan Gosmain · 2019 · Molecular Metabolism
91. Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes
    Tarek Benameur, Aisha Osman, Aijaz Parray, Ali Ait Hssain, Shankar Munusamy, Abdelali Agouni · 2019 · Oxidative Medicine and Cellular Longevity
92. Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
    Ishita Gupta, Balsam R. Rizeq, Semir Vranić, Ala‐Eddin Al Moustafa, Halema F. Al Farsi · 2020 · International Journal of Molecular Sciences
93. Association of subcutaneous and visceral fat with circulating microRNAs in a middle-aged Japanese population
    Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Mirai Yamazaki, Yoshiki Tsuboi, Mari Kondo, Genki Mizuno, Hiroaki Ishikawa, Keiko Sugimoto, Keisuke Osakabe et al. · 2017 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
94. Circulating angiopoietin-2 and angiogenic microRNAs associate with cerebral small vessel disease and cognitive decline in older patients reaching end-stage renal disease
    Roel Bijkerk, Marije H. Kallenberg, Laurien E. Zijlstra, Bernard M. van den Berg, Jeroen de Bresser, Sebastiaan Hammer, Esther E. Bron, Hakim C. Achterberg, Mark A. van Buchem, Noeleen C. Berkhout-Byrne et al. · 2020 · Nephrology Dialysis Transplantation
95. The role of non-coding RNA on macrophage modification in tuberculosis infection
    Zhaohui Wang, Hui Xu, Zhenhong Wei, Yanjuan Jia, Yu Hsuan Wu, Xiaoming Qi, Yuanting Li, Xiaoling Gao · 2020 · Microbial Pathogenesis
96. The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications
    Adelaide Ohui Fierti, Michael Bright Yakass, Ernest Okertchiri, Samuel Mawuli Adadey, Osbourne Quaye · 2022 · Biomolecules
97. Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
    Nihal Satyadev, Milagros I. Rivera, Nicole Kiril Nikolov, Adegbenro Omotuyi John Fakoya · 2023 · Frontiers in Physiology
98. The rs225017 Polymorphism in the 3′UTR of the Human DIO2 Gene Is Associated with Increased Insulin Resistance
    Leonardo Barbosa Leiria, José Miguel Dora, Simone Magagnin Wajner, Aline A. F. Estivalet, Daisy Crispim, Ana Luiza Maia · 2014 · PLoS ONE
99. MALAT1 via microRNA‐17 regulation of insulin transcription is involved in the dysfunction of pancreatic β‐cells induced by cigarette smoke extract
    Qian Sun, Hui Xu, Junchao Xue, Qianlei Yang, Chao Chen, Ping Yang, Aohan Han, Qingyun Tu, Jiachun Lü, Xiaohua Gao et al. · 2018 · Journal of Cellular Physiology
100. Structure before function: myosin binding protein‐C slow is a structural protein with regulatory properties
     Janelle Geist, Christopher W. Ward, Aikaterini Kontrogianni‐Konstantopoulos · 2018 · The FASEB Journal